Regeneron Pharmaceuticals (REGN.US) Q3 results exceed expectations, raises full-year net product margin guidance
智通财经2026/10/30 11:07Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
According to Zhitong Finance APP, Regeneron Pharmaceuticals (REGN.US) has released its results for the third quarter of 2026: total revenue was $5.1158 billion, an increase of 36.3% year-on-year, exceeding the IBES consensus expectation of $4.542 billion. GAAP diluted earnings per share were $18.45, up 35.5% year-on-year. Non-GAAP diluted earnings per share were $20.07, up 69.7% year-on-year, about 24% higher than the IBES forecast of $16.20.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Dow Jones rises 0.41%, Nasdaq falls 1.07%, S&P 500 falls 0.51%
智通财经•2026/11/02 21:51
Spot gold surpasses $3,940 per ounce, up 1.63% intraday.
智通财经•2026/11/02 20:40
Crypto prices
More
Bitcoin
BTC
$76,720.84
-1.31%
Ethereum
ETH
$2,254.85
-0.21%
Tether USDt
USDT
$0.9983
-0.04%
BNB
BNB
$698.7
-1.21%
XRP
XRP
$1.25
+0.16%
USDC
USDC
$0.9996
-0.02%
Solana
SOL
$92.09
-2.24%
TRON
TRX
$0.3185
+1.86%
Hyperliquid
HYPE
$84.48
-3.70%
Zcash
ZEC
$1,157.6
-6.12%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now